乳腺癌筛查中的X线剂量测定:二维与三维乳腺摄影
本文综述了乳腺X线摄影中平均腺体剂量(MGD)估算的主要剂量学形式体系,并梳理了过去四十年降低吸收剂量的持续努力。剂量学方案最初为乳腺摄影制定,后扩展至数字乳腺断层合成(DBT)联合合成数字乳腺摄影(SDM)或数字乳腺摄影(DM)的技术。
要点
- MGD估算的准确性直接关系到辐射相关风险评估和筛查项目优化。
- 剂量学方案最初针对乳腺摄影制定,现已扩展至DBT联合SDM或DM。
- 过去四十年持续努力降低乳腺X线成像的吸收剂量。
核心结论
- MGD估算对理解乳腺X线成像检查的辐射相关风险至关重要,其准确性直接关系到风险评估和筛查项目优化。
- 剂量学方案最初为乳腺摄影制定,后扩展至DBT联合SDM或DM的技术。
研究设计与样本
- 本文为综述,回顾了用于估算乳腺摄影中MGD的主要剂量学形式体系及过去四十年降低吸收剂量的持续努力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
According to the World Health Organization (WHO), at the end of 2020, 7.8 million women alive were diagnosed with breast cancer in the past 5 years, making it the world's most prevalent cancer. It is largely recognized and demonstrated that early detection represents the first strategy to follow in the fight against cancer. The effectiveness of mammography screening for early breast cancer detection has been proven in several surveys and studies over the last three decades. The estimation of the Mean Glandular Dose (MGD) is important to understand the radiation-associated risk from breast x-ray imaging exams. It continues to be the subject of numerous studies and debates, since its accuracy is directly related to risk estimation and for optimizing breast cancer screening programs. This manuscript reviews the main dosimetry formalisms used to estimate the MGD in mammography and to understand the continuing efforts to reduce the absorbed dose over the last forty years. The dosimetry protocols were formulated initially for mammography. Digital breast tomosynthesis (DBT) either in conjunction with synthesized digital mammogram (SDM) or with digital mammography (DM), is routinely used in many breast cancer screening programs and consequently the dosimetry protocols were extended for these techniques.
引用
- Di Maria, Vedantham, Vaz, et al. X-ray dosimetry in breast cancer screening: 2D and 3D mammography. Eur J Radiol. 2022. PMID: 35430441. doi:10.1016/j.ejrad.2022.110278
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。